Metabolomic biomarkers for the diagnosis and post-transplant outcomes of afp negative hepatocellular carcinoma

HIGHLIGHTS

• who: Zuyuan Lin and colleagues from the of Bologna, Italy have published the research: Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma, in the Journal: (JOURNAL)
• what: The model showed good discrimination (AUROC=0.913, 95%CI 0.848-0.977, P and amp;lt;0.001) and calibration (HL P=0.739).
• how: The authors collected the data including demographics body mass index (BMI) pre- operative AFP level alanine transaminase (ALT) level aspartate transaminase (AST) level morphological features (tumor number and largest tumor size) skeletal muscle . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.